Fundraising Fox
Phyllome
11 employees on LinkedIn · 1 known investors
Find your way into Phyllome
Each arrow is one introduction. Sign up to fill in the first one.
Ask David Burt to introduce you to Sebastien Eckersley-Maslin
You →David · together at Phyllome →Sebastien
Sign up to find every way you can get introduced to Phyllome
- Your email: who you already know at Phyllome, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Phyllome team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Phyllome grows edible plants engineered to express cyclotide therapeutic peptides, turning them into functional foods with controlled therapeutic dosing as an oral alternative to injected or synthetic drugs. Its pipeline targets analgesic, cholesterol-modulating, and appetite-regulating applications, developed with the University of Queensland's Institute for Molecular Bioscience.
Founders & leadership
Investors · 1
How we know: Tenacious Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Phyllome do?
- Phyllome grows edible plants engineered to express cyclotide therapeutic peptides, turning them into functional foods with controlled therapeutic dosing as an oral alternative to injected or synthetic drugs. Its pipeline targets analgesic, cholesterol-modulating, and appetite-regulating applications, developed with the University of Queensland's Institute for Molecular Bioscience.
- Who founded Phyllome?
- Phyllome was founded by Sebastien Eckersley-Maslin.
- Who are Phyllome's investors?
- Phyllome's investors include Tenacious Ventures.